44 populationsfarmakokinetiske analyser ledsagedes øgede serumkoncentrationer af total bilirubin af en langsommere hastighed af erlotinib- clearance.
In population pharmacokinetic analysis, increased serum concentrations of total bilirubin were associated with a slower rate of erlotinib clearance.